3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow episalvan: new trials by email Literature Review of episalvan trials Research Report on episalvan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa Oleogel-S10, Control gel - Epidermolysis Bullosa | Phase 3 | Completed | Amryt Research Limited | 223 | 2017-03-29 | 2023-07-20 |
| Oleogel-S10 in Wound Healing of Split-Thickness Skin Graft Donor Sites (BSG-12) Oleogel-S10, non-adhesive wound dressing, Non-adhesive wound dressing only - Wounds | Phase 3 | Completed | Birken AG | 112 | 2013-03-01 | 2018-07-19 |
| Oleogel-S10 in Wound Healing of Split-Thickness Skin Graft Donor Sites (BSH-12) Oleogel-S10, non-adhesive wound dressing, Non-adhesive wound dressing only - Wounds | Phase 3 | Completed | Birken AG | 107 | 2012-08-01 | 2018-01-23 |
Wounds and Injuries (2) · Epidermolysis Bullosa (1)
Birken AG (2) · Amryt Research Limited (1)
Austria (2) · Czechia (2) · France (2) · Germany (2) · Greece (2) · Spain (2) · Argentina (1) · Australia (1) · Brazil (1) · Bulgaria (1) · Chile (1) · Colombia (1) · Denmark (1) · Finland (1) · Georgia (1)
Hans Robert Metelmann, Prof (1) · Johannes S Kern, MD PhD (1) · Juan Pedro Barret Nerin, MD (1)
PMID 28400148, PMID 31186047, PMID 42205007
2016 (1)